FOCP, EHS to drive cancer detection efforts
Friends of Cancer Patients (FOCP) and Emirates Health Services (EHS) have signed a new partnership at Sofitel Dubai The Obelisk, to enhance cooperation in cancer prevention, early detection, and to provide both moral and financial support to patients across the UAE.
The agreement, signed by Dr Shamsa Majid Lootah, Director of the Public Health Department at EHS, and Aisha Al Mulla, Director of FOCP, underscores FOCP's ongoing commitment to working collaboratively with national healthcare institutions to benefit the wider community. It sets out a framework for expanding early detection programmes and strengthening both financial and emotional assistance for patients.
EHS has long been a strategic partner of FOCP, with both organisations having previously joined forces on cancer awareness initiatives.
The renewed partnership provides a platform to broaden the scope of collaboration and align efforts in support of the UAE's national strategy to curb cancer prevalence and lessen its impact on patients and their families.
Commenting on the partnership, Dr. Essam Al Zarouni, Acting Executive Director of the Medical Services Sector at EHS, affirmed that the MoU represents an advanced integration model among national sectors pursuing the country's healthcare goals. This collaboration aligns with the National Strategy for Wellbeing 2031 objectives and the UAE Centennial 2071. For her part, Dr Shamsa Lootah highlighted that EHS is committed to expanding strategic partnerships with key community stakeholders to support its focus on disease prevention and early detection, particularly for cancer.
Through ongoing awareness programmes and initiatives, EHS aims to raise public awareness, encourage healthy lifestyles and improve early diagnosis and treatment, in line with its commitment to comprehensive healthcare.
Aisha Al Mulla, Director of FOCP, said: 'The new partnership with EHS represents a significant step forward in our shared mission to raise community awareness of cancer and strengthen patient support systems. It builds on a longstanding collaboration between us.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hi Dubai
13-06-2025
- Hi Dubai
Dubai Health Authority Approves Yas Healthcare to Build UAE's First Proton Therapy Centre
Dubai is set to become home to the UAE's first proton therapy centre, as the Dubai Health Authority (DHA) has granted initial approval to Yas Healthcare, a subsidiary of Das Holding, for the groundbreaking project. The facility, slated to begin construction in early 2026 and open by late 2028, marks a major step forward in the country's fight against cancer. The Yas Proton Therapy Centre will introduce one of the most advanced forms of cancer treatment to the region. Proton therapy delivers highly targeted radiation to tumours, significantly reducing damage to surrounding healthy tissue. This precision makes it particularly effective for paediatric cancers and tumours near vital organs. 'This centre will offer world-class, patient-focused care, reinforcing Dubai's position as a hub for advanced medical innovation,' said Dr. Alawi Alsheikh-Ali, Director-General of DHA. He highlighted the project's alignment with Dubai's long-term health strategies, including the Dubai Economic Agenda D33 and the National Strategy for Wellbeing 2031. Developed in collaboration with the National Cancer Centre Singapore (NCCS), a leader in oncology, the project will benefit from global clinical and technical expertise. NCCS will serve as the project consultant throughout the design and implementation phases. Dr. Mohamad Zaki of Yas Healthcare emphasized the growing need for such treatment, citing rising cancer rates and the advantages of proton therapy in reducing long-term side effects. Once operational, the centre will eliminate the need for regional patients to travel abroad for this specialised care, supporting Dubai's medical tourism goals and improving access to cutting-edge cancer treatment across the GCC. News Source: Emirates News Agency
Al Etihad
12-06-2025
- Al Etihad
DHA grants initial approval to Yas Healthcare to set up UAE's first proton therapy centre in Dubai
12 June 2025 18:10 DUBAI (WAM) The Dubai Health Authority (DHA) has accorded initial approval to Yas Healthcare, a subsidiary of Das Holding, to establish the UAE's first proton therapy centre in Dubai, marking a historic milestone in the advancement of cancer care in the region. The state-of-the-art facility is expected to be completed by late 2028, with construction slated to start in early will be the first dedicated centre in the UAE to offer proton therapy, a highly advanced and precise form of radiation therapy that targets tumours with exceptional accuracy while sparing healthy tissue. The treatment is especially effective for paediatric cancers and tumours located near sensitive Dubai Health Authority, Dr. Alawi Alsheikh-Ali, stated, 'Under the visionary leadership of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister, and Ruler of Dubai, and His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister, Minister of Defence, and Chairman of The Executive Council of Dubai, we are committed to positioning Dubai as a global leader in healthcare. This proton therapy centre will enhance patient care, offering world-class, patient-centred treatment and improving access to specialised care that ensures better outcomes.''This groundbreaking technology will advance cancer treatment options for our community and reinforce Dubai's goal of ranking among the top 10 cities globally for healthy life expectancy. It also strengthens Dubai's position as a key destination for advanced medical care and innovation, in line with the National Strategy for Wellbeing 2031, Dubai Social Agenda 33, and the Dubai Economic Agenda D33.'Proton therapy is a highly precise and advanced radiation treatment that delivers targeted doses to cancerous tumours while sparing surrounding healthy tissue. This minimises side effects and is particularly effective for treating paediatric cancers and complex or sensitive tumour sites. The Yas Proton Therapy Centre will provide patients across the region with access to this specialised treatment for the first time, eliminating the need to travel abroad for project will be developed in strategic collaboration with the National Cancer Centre Singapore (NCCS), one of Asia's leading authorities in oncology. NCCS will serve as the project consultant, bringing global clinical and technical expertise to the design and implementation of the Director and General Manager of Yas Healthcare, Dr. Mohamad Zaki, said, 'Global data indicates a rising number of cancer diagnoses, particularly among younger patients. Proton therapy provides a treatment option with fewer side effects and lower toxicity for certain cancer types. The Yas Proton Therapy Centre aims to improve accessibility and reduce costs by offering this treatment closer to home.'Chair of the Division of Radiation Oncology at the National Cancer Centre Singapore, Dr. Michael Wang, added, 'This milestone collaboration with Yas Healthcare reflects the National Cancer Centre Singapore's leadership in radiation oncology, operating one of the largest proton beam facilities in Southeast Asia. We are excited to contribute our expertise as Yas Healthcare introduces this advanced technology to redefine cancer treatment in the GCC.'The move to develop the new facility directly aligns with the National Strategy for Wellbeing 2031, the Dubai Social Agenda 33, and the Dubai Economic Agenda D33 — key initiatives to enhance quality of life, improve health outcomes, and position Dubai as a premier destination for medical innovation and tourism. Dubai's Medical Tourism Vision also aims to attract more than 500,000 international patients annually by work related to the project is scheduled to begin in early 2026 and the facility is expected to be operational by the end of 2028. Yas Healthcare's official platforms will provide updates on the progress of the project and patient enrolment programmes.
Sharjah 24
11-06-2025
- Sharjah 24
‘Pink October' encourages awareness to prioritise breast health
To provide tailored support and awareness to the UAE workforce, FOCP encourages companies and institutions across the nation to play a crucial role in the ongoing fight against breast cancer by partnering with the Pink Caravan and making its vital services accessible to their employees. Social responsibility and awareness Corporate participation is essential in amplifying the reach and impact of breast cancer awareness efforts. By partnering with the Pink Caravan initiative, companies can demonstrate their commitment to social responsibility and actively contribute to enhancing the health and well-being of women and men in the workplace. 'Early detection saves lives and it's a responsibility we all share,' said Aisha Al Mulla, Director of FOCP. 'In the UAE, companies and corporations are pillars of our community, so their platforms, networks, and influence can play a transformative role in promoting awareness, encouraging screenings, and supporting a culture of proactive health. Through our Pink October campaign, we urge business leaders and industry decision-makers to step up, speak out, and join us in championing the importance of early detection. Together, we can build a healthier, stronger, and more resilient society.' Tailored options for corporate and institutional entities This year's Pink October campaign offers a range of tailored solutions to encourage corporate involvement, designed to make participation impactful and effective. Companies can book Pink October's mobile clinic to visit their premises, providing expert-led mammogram screenings for female employees aged 40 and above, as well as clinical breast examinations for women and men aged 20 and above. These services are delivered with the utmost professionalism and privacy, ensuring a comfortable and supportive experience for all participants. For organisations seeking a comprehensive approach to employee health, the Pink October Corporate Wellness Day is ideal, combining clinical breast examination, mammogram vouchers, and engaging awareness lectures that empower staff with life-saving knowledge. In addition to these core offerings, companies can also benefit from Mini Mobile Clinics, which provide screening services at the workplace. They can also book awareness seminars and workshops, available both onsite and online. These educational sessions are designed for both women and men, covering the essentials of breast self-examination and the importance of early detection. They are complemented by informative brochures distributed to all attendees. The impact of Pink Caravan and their Pink October campaign is clear, and year after year, thousands of women and men across the UAE gain access to screenings and educational resources, thanks to the support of forward-thinking corporate partners. Corporate bookings for the Pink October campaign are now open, and to reserve your Mobile Clinic, Corporate Wellness Day, or Awareness Seminar, simply email the Pink October team at
